Table 1.
PDB code | species | resolna | type | chain | ligands and prosthetic groups | S···O interactions | S···N interaction | |||
---|---|---|---|---|---|---|---|---|---|---|
|
|
|||||||||
dS(C44)···O(D40)b | dS(C61)···O(A55)c | dS(C84)···O(C96)d | dS(C98)···O(F94)e | dS(M8)···N(R100) | ||||||
1BP2 | bovine | 1.7 | WT | – | Ca2+, MPDf | 0.090 | 0.063 | 0.165 | 0.086 | −0.025 |
1BPQ | bovine | 1.8 | K56M | – | Ca2+ | −0.262 | 0.015 | 0.128 | −0.066 | |
1C74 | bovine | 1.9 | K53M, K56M | A | Ca2+ | 0.113 | −0.070 | 0.130 | 0.179 | −0.020 |
1CEH | bovine | 1.9 | D99N | – | Ca2+ | 0.039 | −0.153 | 0.094 | 0.092 | −0.025 |
1FDK | bovine | 1.96 | WT | – | Ca2+, GLEg | −0.214 | 0.069 | 0.156 | −0.009 | |
1G4I | bovine | 0.97 | WT | A | Ca2+, Cl–, MPDf | 0.127 | −0.018 | 0.117 | 0.099 | −0.034 |
1GH4 | bovine | 1.9 | K56M, K120M, K121M | A | Ca2+, MPDf | |||||
1IRB | bovine | 1.7 | K120A, K121A | – | Ca2+ | 0.022 | −0.003 | 0.172 | 0.091 | 0.186 |
1KVW | bovine | 1.95 | H48Q | – | Ca2+ | 0.006 | 0.052 | 0.191 | 0.181 | |
1KVX | bovine | 1.9 | D99A | – | Ca2+ | 0.024 | 0.058 | −0.070 | 0.088 | 0.120 |
1KVY | bovine | 1.9 | D49E | – | Ca2+ | 0.046 | 0.070 | 0.115 | −0.059 | 0.096 |
1MKS | bovine | 1.9 | Y52F, Y73F, D99N | – | Ca2+ | 0.086 | −0.176 | 0.065 | 0.184 | |
1MKT | bovine | 1.72 | WT | – | Ca2+ | 0.022 | 0.014 | 0.136 | 0.098 | |
1MKU | bovine | 1.8 | Y52F, Y73F, D99N | – | Ca2+ | 0.097 | 0.183 | 0.095 | 0.169 | |
1MKV | bovine | 1.89 | WT | – | Ca2+, GELh | 0.006 | −0.090 | 0.096 | 0.167 | 0.148 |
1O3W | bovine | 1.85 | K53M, K56M, K120M | A | Ca2+, MPDf | 0.174 | −0.221 | 0.115 | 0.134 | 0.025 |
2BPP | bovine | 1.82 | WT | – | Ca2+ | −0.150 | 0.024 | 0.134 | 0.000 | |
1FX9 | porcine | 2.0 | WT | A | Ca2+, SO42–, MJIi | 0.137 | 0.197 | 0.002 | 0.041 | 0.130 |
WT | B | Ca2+, SO42–, MJIi | 0.087 | −0.256 | ||||||
1FXF | porcine | 1.85 | WT | A | Ca2+, PO43–, MJIi | 0.086 | −0.123 | −0.016 | 0.060 | |
WT | B | Ca2+, PO43–, MJIi | 0.120 | 0.193 | 0.031 | −0.140 | ||||
1HN4 | porcine | 1.4 | WT | A | Ca2+, SO42–, MJIi | 0.162 | −0.237 | 0.154 | 0.024 | −0.016 |
WT | B | Ca2+, SO42–, MJIi | 0.134 | −0.020 | 0.110 | 0.027 | −0.116 | |||
1KVO | human | 2.0 | engineered | A | Ca2+, OAPj | 0.053 | 0.048 | −0.033 | ||
engineered | B | Ca2+, OAPj | −0.165 | 0.060 | ||||||
1LE6 | human | 1.97 | engineered | A | Ca2+, MPDf | 0.089 | 0.003 | 0.134 | −0.039 | k |
engineered | B | Ca2+, MPDf | 0.131 | 0.036 | −0.043 | 0.041 | k |
Only commonly observed interactions (dS···X≤0.2 Å) are listed in the table. The values of dS···X are given in Å. Empty columns mean that the corresponding values of dS···X are more than 0.2 Å. The numbers in bold correspond to strong S···X interactions with dS···X≤0.1 Å.
Resolution in Å.
dS(C44)···O(E40) for pig, dS(C43)···O(A39) for 1KVO, and dS(C42)···O(A38) for 1LE6.
dS(C58)···O(A53) for 1LE6.
dS(C77)···O(C88) for 1KVO and dS(C76)···O(C88) for 1LE6.
dS(C90)···O(Q86) for 1KVO and dS(C90)···O(L86) for 1LE6.
2-Methyl-2,4-pentanediol.
1-Hexadecyl-3-trifluoroethyl-sn-glycero-2-phosphomethanol.
1-O-Octyl-2-heptylphosphonyl-sn-glycero-3-phosphoethanolamine.
1-Hexadecyl-3-trifluoroethyl-sn-glycero-2-phosphate methane.
4-(S)-[(1-Oxo-7-phenylheptyl)amino]-5-[4-(phenylmethyl)phenylthio]pentanoic acid.
The corresponding Met residue is not present.